Effects of defibrotide on peripheral obliterative vascular diseases. 1986

O N Ulutin, and N Ilhan-Berkel, and H Tunali, and M Ozer, and S Balkuv-Ulutin, and C Onsel, and I Urgancioğlu

Twenty-nine patients with atherosclerotic obliterative vascular disorder and 9 cases of Buerger's disease were treated with 600 mg defibrotide daily for 10 days and then three times weekly for 3 months. The response to therapy was evaluated from hemostatic parameters, venostasis test (cuff test), treadmill testing, and radionuclide arteriography. We observed increased pain-free intervals in daily life and during treadmill testing. There was also a significantly higher response in the cuff test and improved perfusion as seen by radionuclide arteriography.

UI MeSH Term Description Entries
D007866 Leg The inferior part of the lower extremity between the KNEE and the ANKLE. Legs
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011089 Polydeoxyribonucleotides A group of 13 or more deoxyribonucleotides in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties. Polydeoxyribonucleotide
D005080 Exercise Test Controlled physical activity which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used. Arm Ergometry Test,Bicycle Ergometry Test,Cardiopulmonary Exercise Testing,Exercise Testing,Step Test,Stress Test,Treadmill Test,Cardiopulmonary Exercise Test,EuroFit Tests,Eurofit Test Battery,European Fitness Testing Battery,Fitness Testing,Physical Fitness Testing,Arm Ergometry Tests,Bicycle Ergometry Tests,Cardiopulmonary Exercise Tests,Ergometry Test, Arm,Ergometry Test, Bicycle,Ergometry Tests, Arm,Ergometry Tests, Bicycle,EuroFit Test,Eurofit Test Batteries,Exercise Test, Cardiopulmonary,Exercise Testing, Cardiopulmonary,Exercise Tests,Exercise Tests, Cardiopulmonary,Fitness Testing, Physical,Fitness Testings,Step Tests,Stress Tests,Test Battery, Eurofit,Test, Arm Ergometry,Test, Bicycle Ergometry,Test, Cardiopulmonary Exercise,Test, EuroFit,Test, Exercise,Test, Step,Test, Stress,Test, Treadmill,Testing, Cardiopulmonary Exercise,Testing, Exercise,Testing, Fitness,Testing, Physical Fitness,Tests, Arm Ergometry,Tests, Bicycle Ergometry,Tests, Cardiopulmonary Exercise,Tests, EuroFit,Tests, Exercise,Tests, Step,Tests, Stress,Tests, Treadmill,Treadmill Tests
D005260 Female Females
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001157 Arterial Occlusive Diseases Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency. Arterial Obstructive Diseases,Arterial Occlusion,Arterial Obstructive Disease,Arterial Occlusions,Arterial Occlusive Disease,Disease, Arterial Obstructive,Disease, Arterial Occlusive,Obstructive Disease, Arterial,Occlusion, Arterial,Occlusive Disease, Arterial

Related Publications

O N Ulutin, and N Ilhan-Berkel, and H Tunali, and M Ozer, and S Balkuv-Ulutin, and C Onsel, and I Urgancioğlu
September 1955, La Riforma medica,
O N Ulutin, and N Ilhan-Berkel, and H Tunali, and M Ozer, and S Balkuv-Ulutin, and C Onsel, and I Urgancioğlu
November 1989, International journal of clinical pharmacology, therapy, and toxicology,
O N Ulutin, and N Ilhan-Berkel, and H Tunali, and M Ozer, and S Balkuv-Ulutin, and C Onsel, and I Urgancioğlu
April 1964, Khirurgiia,
O N Ulutin, and N Ilhan-Berkel, and H Tunali, and M Ozer, and S Balkuv-Ulutin, and C Onsel, and I Urgancioğlu
January 1989, Clinical therapeutics,
O N Ulutin, and N Ilhan-Berkel, and H Tunali, and M Ozer, and S Balkuv-Ulutin, and C Onsel, and I Urgancioğlu
February 1952, Acta medica Scandinavica,
O N Ulutin, and N Ilhan-Berkel, and H Tunali, and M Ozer, and S Balkuv-Ulutin, and C Onsel, and I Urgancioğlu
January 1989, La Ricerca in clinica e in laboratorio,
O N Ulutin, and N Ilhan-Berkel, and H Tunali, and M Ozer, and S Balkuv-Ulutin, and C Onsel, and I Urgancioğlu
September 1960, Die Medizinische Welt,
O N Ulutin, and N Ilhan-Berkel, and H Tunali, and M Ozer, and S Balkuv-Ulutin, and C Onsel, and I Urgancioğlu
January 1990, International angiology : a journal of the International Union of Angiology,
O N Ulutin, and N Ilhan-Berkel, and H Tunali, and M Ozer, and S Balkuv-Ulutin, and C Onsel, and I Urgancioğlu
March 1969, Voenno-meditsinskii zhurnal,
O N Ulutin, and N Ilhan-Berkel, and H Tunali, and M Ozer, and S Balkuv-Ulutin, and C Onsel, and I Urgancioğlu
January 1957, Bullettino delle scienze mediche,
Copied contents to your clipboard!